About the Mood and Anxiety Disorders Program

The Mood and Anxiety Disorders Program (MAP) in the Department of Psychiatry at Mount Sinai School of Medicine is devoted to understanding the causes of mood and anxiety disorders and aims to advance new treatments to improve the quality of life for patients who are affected by them. MAP at Mount Sinai uses state-of-the-art brain imaging, genetic, and clinical trials methods to enhance our understanding of brain processes associated with these disorders.

Treatment Services

In addition to conducting research studies, our programs also serves as a tertiary care referral center for patients with the most serious and debilitating forms of depression (called treatment-resistant depression). For patients referred to us, we conduct a comprehensive diagnostic evaluation. We have several research protocols for difficult-to-treat depressions.

Mood and anxiety disorders can affect anyone. They are not specific to age, gender, race, or socioeconomic status. While one's environment can play a role in the manifestation of symptoms, these disorders are also rooted in genetics and occur involuntarily. Many mood and anxiety disorders are treatable with a high degree of success with medications, psychotherapies, and behavioral interventions.

Clinical Trials

MAP at Mount Sinai is currently conducting several research studies in mood and anxiety disorders. All of our participants will receive reimbursement for their time, and all treatment studies are conducted entirely free of charge. Through research and clinical treatment, our MAP experts address Mood and Anxiety Disorders such as:

• Major Depressive Disorder – find clinical trials
• Bipolar Disorder – find clinical trials
• Post-Traumatic Stress Disorder (PTSD) – find clinical trials